AI & Quantum Computing Tempus AI’s Rally Rests on a Vaccine Catalyst — and a Not-Yet-Completed Deal
The stock market has a habit of pricing in tomorrow’s headlines today, and Tempus AI’s recent surge is a textbook case. Shares of the precision-medicine company have more than doubled...